Dr. Grady Rylander, professor of biomedical engineering at The University of Texas at Austin, has joined Mystic Pharmaceutical's scientific advisory board.
Dr. Grady Rylander, professor of biomedical engineering at The University of Texas at Austin, has joined Mystic Pharmaceutical's scientific advisory board.
Grady Rylander
Mystic is an Austin-based company providing patient-centric delivery solutions for pharamceuticals, biopharmaceuticals, and biologics for intranasal, ophthalmic, sublingual, and optic applications.
"Dr. Rylander's experience as a board certified ophthalmologist and clinical practice, combined with his biomedical engineering expertise provides Mystic's team with a tremendous knowledge base in the development of patient-centric ophthalmic drug delivery systems," said Timothy Sullivan, Mystic's President and CEO.
Rylander is researcher and physician with a special interest in retina, glaucoma, and cataract. He has been in practice for 34 years and is on the staff of seven Texas hospitals. He has performed thousands of cataract surgeries and hundreds of laser procedures through his ophthalmic practice at the Eye Institute of Austin. He has three issued patents and has authored or co-authored more than 125 scholarly articles within the field of ophthalmology and biomedical engineering. Dr. Rylander attended The University of Texas at Austin where he earned BSEE and MSEE degrees. He received his M.D. from the University of Texas Health Science Center at San Antonio in 1980. Dr. Rylander is the Harry H. Power Professor in Engineering and a William J. Murray, Jr. Fellow in Engineering.
